Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1995-05-05
1996-08-20
Budens, Robert D.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
4241541, 4241731, 4241781, 435 7021, 4351722, 43524027, 5303917, 5303911, 53038875, 5303896, A61K 39395, C07K 1628, C21P 2108
Patent
active
055476686
ABSTRACT:
The present invention provides a process of targeting folate-receptor-positive tumor cells for lysis by binding a conjugate of folate and an anti-T-cell-receptor antibody or an anti-Fc receptor antibody to those cells. A process of lysing folate-receptor-positive tumor cells comprising exposing the cells to a folate/anti-T-cell-receptor antibody in the presence of a population of T-cells is also provided. A process of lysing folate-receptor-positive tumor cells comprising exposing the cells to a folate/anti-Fc receptor antibody in the presence of a population of natural killer cells, monocytes, or macrophages is also provided. Still further, the present invention provides a conjugate of folate to an anti-T-cell-receptor antibody or an anti-Fc receptor antibody.
REFERENCES:
patent: 5030719 (1991-07-01), Umemoto et al.
patent: 5070877 (1991-12-01), Mohiuddin et al.
patent: 5108921 (1992-04-01), Low et al.
patent: 5140104 (1992-08-01), Coughlin et al.
Fanger et al (1990). Faseg J. 4(11) 2846-2849.
Leaman et al (1993) J. Biol. Chem. vol. 268 (33) 24847-24854.
Brigle, K. E., Spinella, M. J., Westin, E. H. & Goldman, I. D. [1994] Biochem Pharmacol 47:337-345.
Brigle, K. E., Seither, R. L., Westin, E. H. & Goldman, I. D. [1994] Biol Chem 269:4267-4272.
Brigle, K. E., Westin, E. H., Houghton, M. T. & Goldman, I. D. [1991] J Biol Chem 266:17243-17249.
Campell, I. G., Jones, T. A., Foulkes, W. D., & Trowsdale, J. [1991] Cancer Res. 51:5329-5338.
Fanger, Morganelli, & Guyre [1992] Crit. Rev. Immunol. 12:101-1240.
Haskins, K., Hannum, C., White, J., Rhoem, N., Kubo, R., Kappler, J. & Marrack, K. [1984] J. Exp. Med. 160:452-471.
Jansen, G., Westerhof, G. R., Kathmann, I., Rademaker, B. C., Rijksen, G., & Schornagel, J. H.[1989] Cancer Res. 49:2455-2459.
Kranz, D. M., Sherman, D. H., Sitkovsky, M. V., Pasternack, M. S. & Eisen, H. N. [1984] Proc. Natl. Acad. Sci. USA 81:573-577.
Kranz, D. M., Tonegawa, S. & Eisen, H. N. [1984] Proc. Natl. Acad. Sci. USA 81:7922-7926.
Leamon, C. P. & Low, P. S. [1992] J Biol Chem 267:24966-24971.
Leo, O., Foo, M., Sachs, D. H., Samelson, L. E. & Bluestone, J. A. [1987] Proc. Natl. Acad. Sci. USA 84:1374.
Miotti S., Canevari, S., Menard, S., Mezzanzanica, D., Porro, G., Pupa, S. M., Regazzoni, M., Tabliabue, E. & Colnaghi, M. I.[1987] Int. J. Cancer 39:297-303.
Ross et al., Cancer 73:2432, 1994.
Schodin, B. A. & Kranz, D. M. [1993] J. Biol. Chem. 268:25722-25727.
Soo Hoo, W. F. & Kranz, D. M. [1993] J. Immunol. 150:4331-4337.
Weitman et al., Cancer Research 52:3396, 1992.
Westerof, G. R., Jansen, G., Van Emmerik, N., Kathmann, I., Rijksen, G., Jackman, A. L. & Schornagel, J. H. et al. [1991] Cancer Research 51:5507-5513.
Kranz David M.
Patrick Todd A.
Roy Edward J.
Budens Robert D.
Reeves Julie E.
The Board of Trustees of the University of Illinois
LandOfFree
Conjugates of folate anti-effector cell antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conjugates of folate anti-effector cell antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugates of folate anti-effector cell antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2328622